MedTrace Logo

Expanded Development of a Medical Device Utilizing an EEG-Based Algorithm for the Objective Quantification of Pain

NCT04585451 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 334

Last updated 2023-05-06

Study results available
· View outcomes & findings →

Summary

PainQx is conducting a study to collect electroencephalography (EEG) data from 250 people with chronic pain and 50 healthy controls in order to develop algorithms that will objectively assess the level of pain a person is experiencing.

Conditions

Interventions

DIAGNOSTIC_TEST

ALGOS System

A Quantitative Electroencephalography (QEEG) based pain biomarker assessment that scales with patient reported Numeric Rating Scale (NRS)

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • PainQx, Inc

    lead INDUSTRY

Principal Investigators

  • William Koppes · PainQx, Inc

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-23
Primary Completion
2022-01-05
Completion
2022-01-05
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04585451 on ClinicalTrials.gov